Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database
Article in Frontiers in Immunology (September 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards
Article in Drug Safety (July 2024)
Optimal p-values and sample size for signal detection methods based on generalised Weibull distributions
Preprint in arXiv (October 2023)